Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 30 citing articles:

Inflammation in osteoarthritis: the latest progress and ongoing challenges
Alexander J. Knights, S Redding, Tristan Maerz
Current Opinion in Rheumatology (2022) Vol. 35, Iss. 2, pp. 128-134
Closed Access | Times Cited: 97
Anti-rheumatoid drugs advancements: New insights into the molecular treatment of rheumatoid arthritis
Reda Ben Mrid, Najat Bouchmaa, Hassan Ainani, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 151, pp. 113126-113126
Open Access | Times Cited: 86
The Impact of the CB2 Cannabinoid Receptor in Inflammatory Diseases: An Update
Volatiana Rakotoarivelo, Thomas Z. Mayer, Mélissa Simard, et al.
Molecules (2024) Vol. 29, Iss. 14, pp. 3381-3381
Open Access | Times Cited: 11
Cannabinoid receptor 2 selective agonist ameliorates adjuvant-induced arthritis by modulating the balance between Treg and Th17 cells
Na Tian, Cui Yang, Yu Du, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
The emerging role of endocannabinoid system modulation in human fibroblast-like synoviocytes: Exploring new biomarkers and potential therapeutic targets
Jakub Chwastek, Marta Kędziora, Małgorzata Borczyk, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 186, pp. 118040-118040
Closed Access
Medical cannabis and its efficacy/effectiveness on the management of osteoarthritis pain and function
Cerina Dubois, Elizabeth C. Danielson, Molly Beestrum, et al.
Current Medical Research and Opinion (2024) Vol. 40, Iss. 7, pp. 1195-1202
Closed Access | Times Cited: 4
Advances in cannabinoid receptors pharmacology: from receptor structural insights to ligand discovery
Siyuan Shen, Chao Wu, Zhiqian Yang, et al.
Acta Pharmacologica Sinica (2025)
Closed Access
A Comprehensive Review on the Regulatory Action of TRP Channels: A Potential Therapeutic Target for Nociceptive Pain
Santosh Anand, Senthilkumar Rajagopal
Neuroscience Insights (2023) Vol. 18
Open Access | Times Cited: 9
A Proteomic View of Cellular and Molecular Effects of Cannabis
Morteza Abyadeh, Vivek Gupta, João A. Paulo, et al.
Biomolecules (2021) Vol. 11, Iss. 10, pp. 1411-1411
Open Access | Times Cited: 23
Single nucleotide polymorphisms in the cannabinoid CB2 receptor: Molecular pharmacology and disease associations
Tahira Foyzun, M.J. Whiting, Kate K. Velasco, et al.
British Journal of Pharmacology (2024) Vol. 181, Iss. 15, pp. 2391-2412
Open Access | Times Cited: 2
H2O2/NIR-sensitive “two-step” nano theranostic system based hollow mesoporous copper sulfide/hyaluronic acid/JWH133 as an optimally designed delivery system for multidimensional treatment of RA
Shang Qiu, Xiunan Wu, Dechun Geng, et al.
International Journal of Biological Macromolecules (2022) Vol. 225, pp. 298-309
Closed Access | Times Cited: 12
Targeting CB2 and TRPV1: Computational Approaches for the Identification of Dual Modulators
Paula Morales, Chanté Muller, Nadine Jagerovic, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 10
Computational Approach Reveals Pronociceptive Potential of Cannabidiol in Osteoarthritis: Role of Transient Receptor Potential Channels
Jakub Mlost, Marta Kędziora, Katarzyna Starowicz
Pharmaceuticals (2021) Vol. 14, Iss. 10, pp. 964-964
Open Access | Times Cited: 13
The Main Therapeutic Applications of Cannabidiol (CBD) and Its Potential Effects on Aging with Respect to Alzheimer’s Disease
Václav Trojan, Leoš Landa, Alexandra Šulcová, et al.
Biomolecules (2023) Vol. 13, Iss. 10, pp. 1446-1446
Open Access | Times Cited: 4
Efficacy of Topical Palmitoylethanolamide (Levagen+) for the Management of Eczema Symptoms: A Double-Blind, Comparator-Controlled, Randomized Clinical Trial
Amanda Rao, Amel A. Moussa, Jane Erickson, et al.
Skin Pharmacology and Physiology (2023) Vol. 36, Iss. 6, pp. 288-295
Open Access | Times Cited: 4
Cannabinoids in Integumentary Wound Care: A Systematic Review of Emerging Preclinical and Clinical Evidence
Dhakshila Niyangoda, Mohammed Muayad, Wubshet Tesfaye, et al.
Pharmaceutics (2024) Vol. 16, Iss. 8, pp. 1081-1081
Open Access | Times Cited: 1
Edge advances in nanodrug therapies for osteoarthritis treatment
Jinfeng Liao, Qinxuan Gu, Zheng Liu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Inhibition of anandamide breakdown reduces pain and restores LTP and monoamine levels in the rat hippocampus via the CB1 receptor following osteoarthritis
Marta Kędziora, Serena Boccella, Ida Marabese, et al.
Neuropharmacology (2022) Vol. 222, pp. 109304-109304
Open Access | Times Cited: 7
Endocannabinoid System Receptors at the Hip and Stifle Joints of Middle-Aged Dogs: A Novel Target for the Therapeutic Use of Cannabis sativa Extract in Canine Arthropathies
Rodrigo Zamith Cunha, Giulia Salamanca, Fanny Mille, et al.
Animals (2023) Vol. 13, Iss. 18, pp. 2833-2833
Open Access | Times Cited: 3
Drug Delivery System Approaches for Rheumatoid Arthritis Treatment: A Review
Anushka Garhwal, Priyadarshi Kendya, Sakshi Soni, et al.
Mini-Reviews in Medicinal Chemistry (2023) Vol. 24, Iss. 7, pp. 704-720
Closed Access | Times Cited: 2
Re-evaluation of the cardioprotective effects of cannabinoids against ischemia-reperfusion injury according to the IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria
Anna Pędzińska‐Betiuk, Eberhard Schlicker, Jolanta Weresa, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Impact of Genetic and Pharmacological Modulation of CB2 Receptors on Morphine-Induced Analgesia, Tolerance, and Reward in C57BL/6J Mice
Massar Omar, Safae Ouzzaouit, Meriem Moussafir, et al.
IBRO Neuroscience Reports (2024)
Open Access
Activation of cannabinoid receptor 2 by turmeric oleoresin reduces inflammation and oxidative stress in an osteoarthritis in vitro model
Federico Ghiselli, Roberta Majer, Andrea Piva, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Cannabinoids in the Inflamed Synovium Can Be a Target for the Treatment of Rheumatic Diseases
Livia Roseti, Giorgia Borciani, Emanuela Amore, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9356-9356
Open Access
Monoacylglycerol Lipase and Cyclooxygenase-2 Expression in Osteoarthritic Human Knees
Mei Yu, Chris Gordon, Keith M. Studholme, et al.
Cannabis and Cannabinoid Research (2023) Vol. 9, Iss. 5, pp. 1370-1376
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top